Related Experiment Video
Updated: Aug 8, 2026
06:09
Adult and Pediatric Porcine Model of Acute Volume Overload
Published on: January 12, 2024
Capitation payment rates and implications for the general pediatrician
1Center for Hospital Finance and Management, Johns Hopkins University, Baltimore, MD 21205, USA.
Current Opinion in Pediatrics
|November 18, 1998
Summary
Pediatricians face financial risks with capitation contracts due to varying child healthcare costs. This review explores payment systems and risk-reduction strategies for pediatric capitation, including physician perspectives.
Area of Science:
- Pediatric healthcare economics
- Healthcare payment models
- Risk management in pediatrics
Background:
- Pediatricians increasingly adopt capitated contracts, agreeing to provide annual care for a set fee.
- Healthcare costs vary significantly among children, particularly for those with chronic illnesses.
- This necessitates adjustments to payment structures to account for diverse patient needs.
Purpose of the Study:
- To review current literature on payment systems for pediatric capitation.
- To identify methods for mitigating financial risks associated with capitated payments for pediatricians.
- To explore physicians' perceptions of how capitation impacts their practice.
Main Methods:
- Literature review of payment systems for capitated rates.
- Analysis of risk-reduction strategies in pediatric capitation.
- Synthesis of physician feedback on the effects of capitation.
Main Results:
- Various capitation payment systems exist to establish equitable rates.
- Strategies for risk adjustment and management are crucial for pediatrician viability.
- Physician perceptions highlight practice changes and challenges under capitation.
Conclusions:
- Capitation models require careful design to manage financial risks in pediatrics.
- Effective risk-sharing and physician support are vital for successful capitation.
- Understanding physician perspectives is key to optimizing pediatric payment systems.
Related Concept Videos
01:20Assessment of Ventilation I: Respiratory Rate
Assessment of Ventilation
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:29Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...